Notice of Meeting, 35876-35877 [2023-11656]

Download as PDF ddrumheller on DSK120RN23PROD with NOTICES1 35876 Federal Register / Vol. 88, No. 105 / Thursday, June 1, 2023 / Notices OMB No. 3064–0184 Total Estimated Annual Burden (Hours): 4,049. General Description of Collection: Section 13 of the Bank Holding Company Act of 1956 (‘‘Section 13’’) contains certain restrictions on the ability of a banking entity to engage in proprietary trading and to have certain interests in, or relationships with, a hedge fund or private equity fund. The FDIC’s regulations at 12 CFR part 351 (part 351) implement Section 13 with respect to FDIC-supervised insured depository institutions (IDIs). The requirements in part 351 do not apply to FDIC-supervised IDIs that have, and if every company that controls it has, total consolidated assets of $10 billion or less and total trading assets and trading liabilities, that are 5 percent or less of total consolidated assets.1 Part 351 contains provisions that constitute information collections (ICs) under the Paperwork Reduction Act corresponding to policies, rules, and regulations regarding periodic reporting requirements, documentation of trading activities and compliance programs, and various other recordkeeping and disclosure requirements for FDICsupervised IDIs that are subject to the requirements of part 351 (covered bank). There is no change in the substance or methodology of this information collection. The estimated annual burden for this information collection is 4,049 hours. This is an increase of 856 hours from the total estimated annual burden of 3,193 hours submitted in 2020. As was the case in the 2020, the FDIC assumes that all covered banks have completed the implementation portions of this information collection. Thus, the current estimated annual implementation burden is identical to the estimated annual implementation burden in 2020 (1,664 hours). The increase in burden is driven entirely by the increase in the total annual ongoing burden which is now estimated to be 2,385 hours, an increase of 856 hours from the estimated annual burden used in 2020 (1,529 hours). Specifically, the number of covered banks considered to have ‘‘significant’’ trading assets and liabilities has increased from one in 2020 to two in the current estimate . . . Generally, the ICs that apply only to these covered banks— such as those under § 351.20(a)— 351.20(e)—have the highest estimated time per response and an increase in the number of respondents will lead to a correspondingly large increase in the total estimated annual burden. This increase is attenuated by a decrease in 1 12 CFR 351.2(r)(2). VerDate Sep<11>2014 17:37 May 31, 2023 Jkt 259001 the total number of covered banks with ‘‘moderate’’ or ‘‘significant’’ trading assets and liabilities from ten in the 2020 ICR to seven in this ICR, which has led to a corresponding decrease in the total estimated annual burden for those line items that apply to all covered banks with ‘‘moderate’’ or ‘‘significant’’ trading assets and liabilities. The total estimated annual hourly burden for both implementation and ongoing compliance is shown in Tables 1 and 2 above Request for Comment Comments are invited on: (a) Whether the collections of information are necessary for the proper performance of the FDIC’s functions, including whether the information has practical utility; (b) the accuracy of the estimates of the burden of the information collections, including the validity of the methodology and assumptions used; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collections of information on respondents, including through the use of automated collection techniques or other forms of information technology. All comments will become a matter of public record. Federal Deposit Insurance Corporation. Dated at Washington, DC, on May 25, 2023. James P. Sheesley, Assistant Executive Secretary. [FR Doc. 2023–11603 Filed 5–31–23; 8:45 am] BILLING CODE 6714–01–P FEDERAL MARITIME COMMISSION Notice of Agreements Filed The Commission hereby gives notice of filing of the following agreements under the Shipping Act of 1984. Interested parties may submit comments, relevant information, or documents regarding the agreements to the Secretary by email at Secretary@ fmc.gov, or by mail, Federal Maritime Commission, 800 North Capitol Street, Washington, DC 20573. Comments will be most helpful to the Commission if received within 12 days of the date this notice appears in the Federal Register, and the Commission requests that comments be submitted within 7 days on agreements that request expedited review. Copies of agreements are available through the Commission’s website (www.fmc.gov) or by contacting the Office of Agreements at (202) 523– 5793 or tradeanalysis@fmc.gov. Agreement No.: 012276–003. PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 Agreement Name: Hapag-Lloyd/Zim Mediterranean Slot Exchange Agreement. Parties: Hapag Lloyd AG; ZIM Integrated Shipping Services Ltd. Filing Party: Wayne Rohde, Cozen O’Connor. Synopsis: The Amendment adds Portugal to the geographic scope of the Agreement and changes the amount of space being exchanged under the Agreement. Proposed Effective Date: 7/3/2023. Location: https://www2.fmc.gov/ FMC.Agreements.Web/Public/ AgreementHistory/135. Agreement No.: 201218–001. Agreement Name: Bi-State Public Marine Terminal Discussion Agreement. Parties: Georgia Ports Authority; South Carolina State Ports Authority. Filing Party: Paul Heylman, Saul Ewing LLP. Synopsis: The amendment removes rate discussion authority from the Agreement. Proposed Effective Date: 7/3/2023. Location: https://www2.fmc.gov/FMC. Agreements.Web/Public/Agreement History/2089. Agreement No.: 201256–002. Agreement Name: Maersk/MSC GulfECSA Vessel Sharing Agreement. Parties: Maersk A/S; Mediterranean Shipping Company S.A. Filing Party: Wayne Rohde, Cozen O’Connor. Synopsis: The Amendment revises the number of vessels to be provided by one of the parties, revises the space allocated to the parties, and changes the contact person for Maersk. Proposed Effective Date: 7/8/2023. Location: https://www2.fmc.gov/ FMC.Agreements.Web/Public/ AgreementHistory/12179. Dated: May 26, 2023. JoAnne O’Bryant, Program Analyst. [FR Doc. 2023–11651 Filed 5–31–23; 8:45 am] BILLING CODE 6730–02–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Healthcare Research and Quality Notice of Meeting Agency for Healthcare Research and Quality (AHRQ), HHS. ACTION: Notice. AGENCY: The Agency for Healthcare Research and Quality (AHRQ) announces a Special Emphasis Panel SUMMARY: E:\FR\FM\01JNN1.SGM 01JNN1 Federal Register / Vol. 88, No. 105 / Thursday, June 1, 2023 / Notices (SEP) meeting on ‘‘Diagnostic Safety in Ambulatory Care.’’ This SEP meeting will be closed to the public. DATES: July 26–27, 2023. Agency for Healthcare Research and Quality (Video Assisted Review), 5600 Fishers Lane, Rockville, Maryland 20857. ADDRESSES: FOR FURTHER INFORMATION CONTACT: Jenny Griffith, Committee Management Officer, Office of Extramural Research, Education and Priority Populations, Agency for Healthcare Research and Quality, (AHRQ), 5600 Fishers Lane, Rockville, Maryland 20857, Telephone: (301) 427–1557. A Special Emphasis Panel is a group of experts in fields related to health care research who are invited by AHRQ, and agree to be available, to conduct on an as needed basis, scientific reviews of applications for AHRQ support. Individual members of the Panel do not attend regularly scheduled meetings and do not serve for fixed terms or a long period of time. Rather, they are asked to participate in a particular review meeting which require their type of expertise. The SEP meeting referenced above will be closed to the public in accordance with the provisions set forth in 5 U.S.C. 1009(d), 5 U.S.C. 552b(c)(4), and 5 U.S.C. 552b(c)(6). Grant applications for ‘‘Diagnostic Safety in Ambulatory Care’’ are to be reviewed and discussed at this meeting. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Agenda items for this meeting are subject to change as priorities dictate. SUPPLEMENTARY INFORMATION: Dated: May 26, 2023. Marquita Cullom, Associate Director. [FR Doc. 2023–11656 Filed 5–31–23; 8:45 am] ddrumheller on DSK120RN23PROD with NOTICES1 BILLING CODE 4160–90–P VerDate Sep<11>2014 17:37 May 31, 2023 Jkt 259001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [CMS–7071–N] Announcement of the Advisory Panel on Outreach and Education (APOE) Virtual Meeting Centers for Medicare & Medicaid Services (CMS), Health and Human Services (HHS). ACTION: Notice. AGENCY: This notice announces the next meeting of the APOE (the Panel) in accordance with the Federal Advisory Committee Act. The Panel advises and makes recommendations to the Secretary of the U.S. Department of Health and Human Services (HHS) (the Secretary) and the Administrator of the Centers for Medicare & Medicaid Services (CMS) on opportunities to enhance the effectiveness of consumer education strategies concerning the Health Insurance Marketplace®, Medicare, Medicaid, and the Children’s Health Insurance Program (CHIP). This meeting is open to the public. DATES: Meeting Date: Thursday, June 22, 2023 from 12 p.m. to 5:00 p.m. eastern daylight time (e.d.t). Deadline for Meeting Registration, Presentations, Special Accommodations, and Comments: Thursday, June 15, 2023 5:00 p.m. (e.d.t). ADDRESSES: Meeting Location: Virtual. All those who RSVP will receive the link to attend. Presentations and Written Comments: Presentations and written comments should be submitted to: Walt Gutowski, Jill Darling, Lisa Carr, Designated Federal Official (DFO), Office of Communications, Centers for Medicare & Medicaid Services, 200 Independence Avenue SW, Mailstop 325G HHH, Washington, DC 20201, 202–690–5742, or via email at APOE@cms.hhs.gov. Registration: Persons wishing to attend this meeting must register at the website https://CMS-APOEJune2023.rsvpify.com or by contacting the DFO listed in the FOR FURTHER INFORMATION CONTACT section of this notice, by the date listed in the DATES section of this notice. Individuals requiring sign language interpretation or other special accommodations should contact the DFO at the address listed in the ADDRESSES section of this notice by the date listed in the DATES section of this notice. SUMMARY: PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 35877 Walt Gutowski, Jill Darling or Lisa Carr, Designated Federal Official, Office of Communications, 200 Independence Avenue SW, Mailstop 325G HHH, Washington, DC 20201, 202–690–5742, or via email at APOE@cms.hhs.gov. Additional information about the APOE is available at: https:// www.cms.gov/Regulations-andGuidance/Guidance/FACA/APOE. Press inquiries are handled through the CMS Press Office at (202) 690–6145. FOR FURTHER INFORMATION CONTACT: SUPPLEMENTARY INFORMATION: I. Background and Charter Renewal Information A. Background The Advisory Panel for Outreach and Education (APOE) (the Panel) is governed by the provisions of the Federal Advisory Committee Act (FACA) (Pub. L. 92–463), as amended (5 U.S.C. Appendix 2), which sets forth standards for the formation and use of federal advisory committees. The Panel is authorized by section 1114(f) of the Social Security Act (the Act) (42 U.S.C. 1314(f)) and section 222 of the Public Health Service Act (42 U.S.C. 217a). The Panel, which was first chartered in 1999, advises and makes recommendations to the Secretary of the U.S. Department of Health and Human Services (the Department) and the Administrator of the Centers for Medicare & Medicaid Services (CMS) on the effective implementation of national Medicare, Medicaid, Children’s Health Insurance Program (CHIP) and Health Insurance Marketplace outreach and education programs. The APOE has focused on a variety of laws, including the Medicare Modernization Act of 2003 (Pub. L. 108– 173), and the Affordable Care Act (Patient Protection and Affordable Care Act, (Pub. L. 111–148) and Health Care and Education Reconciliation Act of 2010 (Pub. L. 111–152)). The APOE helps the Department determine the best communication channels and tactics for various programs and priorities, as well as new rules and legislation. In the coming years, we anticipate the American Rescue Plan, the Inflation Reduction Act, and the SUPPORT Act will be some of the topics the Panel will discuss. The Panel will provide feedback to CMS staff on outreach and education strategies, communication tools and messages and how to best reach minority, vulnerable and Limited English Proficiency populations. E:\FR\FM\01JNN1.SGM 01JNN1

Agencies

[Federal Register Volume 88, Number 105 (Thursday, June 1, 2023)]
[Notices]
[Pages 35876-35877]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-11656]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Agency for Healthcare Research and Quality


Notice of Meeting

AGENCY: Agency for Healthcare Research and Quality (AHRQ), HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Agency for Healthcare Research and Quality (AHRQ) 
announces a Special Emphasis Panel

[[Page 35877]]

(SEP) meeting on ``Diagnostic Safety in Ambulatory Care.'' This SEP 
meeting will be closed to the public.

DATES: July 26-27, 2023.

ADDRESSES: Agency for Healthcare Research and Quality (Video Assisted 
Review), 5600 Fishers Lane, Rockville, Maryland 20857.

FOR FURTHER INFORMATION CONTACT: Jenny Griffith, Committee Management 
Officer, Office of Extramural Research, Education and Priority 
Populations, Agency for Healthcare Research and Quality, (AHRQ), 5600 
Fishers Lane, Rockville, Maryland 20857, Telephone: (301) 427-1557.

SUPPLEMENTARY INFORMATION: A Special Emphasis Panel is a group of 
experts in fields related to health care research who are invited by 
AHRQ, and agree to be available, to conduct on an as needed basis, 
scientific reviews of applications for AHRQ support. Individual members 
of the Panel do not attend regularly scheduled meetings and do not 
serve for fixed terms or a long period of time. Rather, they are asked 
to participate in a particular review meeting which require their type 
of expertise.
    The SEP meeting referenced above will be closed to the public in 
accordance with the provisions set forth in 5 U.S.C. 1009(d), 5 U.S.C. 
552b(c)(4), and 5 U.S.C. 552b(c)(6). Grant applications for 
``Diagnostic Safety in Ambulatory Care'' are to be reviewed and 
discussed at this meeting. The grant applications and the discussions 
could disclose confidential trade secrets or commercial property such 
as patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.
    Agenda items for this meeting are subject to change as priorities 
dictate.

    Dated: May 26, 2023.
Marquita Cullom,
Associate Director.
[FR Doc. 2023-11656 Filed 5-31-23; 8:45 am]
BILLING CODE 4160-90-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.